Kuang Tien General Hospital
Taichung, 433, Taiwan
NCT Number: NCT03933553
Sleep disorders affect human health tremendously. It has been reported that aromatherapy by fragrance inhalation can be used as an adjuvant therapy to modulate parasympathetic nervous activity for relieving stress and mood, and promoting sleep quality. Many researches confirmed that lavender essential oil can be used as an adjuvant therapy for sleep disorders. It can effectively relieve stress and modulate physical and mental status. However, many studies about aromatherapy lack sleep detection instruments to objectively confirm their effects on sleep physiology. Therefore, this study adopts Easy sleep complex essential oil as the experimental group. The lavender essential oil containing orange, petitgrain, rose, lavender, rosewood, ho wood, amyris essential oil and lavender oil is chosen as control group. The subjects will be randomly assigned to one of the two groups. The efficacy results will be evaluated and compared between the two groups. The investigators expect that aromatherapy by fragrance inhalation with Easy sleep complex essential oil will improve sleep quality more effectively than lavender essential oil.
Looking for future studies?
Notify Me20 year–65 year
All sexes
Interventional
Not applicable
Taichung, 433, Taiwan
A Randomized, Single-blind, Active-Controlled Trial to Evaluate the aromatherapy by fragrance inhalation using Easy sleep complex essential oil in patients with sleep disorders.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
the aromatherapy by fragrance inhalation
Time frame: 2 days
measure the alpha wave(8-14Hz), Vertex sharp wave(4-7Hz), K complex (negative- positive sharp component area), Spindle(7-14Hz for at least 0.5 sec), theta wave(4-7Hz), and delta wave(0.5-3Hz, amplitude>75uV).
Time frame: 2 days
a record of the difference in electrical charge between the front and back of the eye
Time frame: 2 days
measure heart rate variability (HRV): change of R-R interval
Time frame: 2 days
recording the electrical activity produced by skeletal muscles
Time frame: 2 days
The amplitude change of chest and abdominal movement
Time frame: 2 days
The amplitude change of nasal pressure and thermistor
Time frame: 2 days
Systolic and Diastolic blood pressure
Time frame: 2 days
saturated hemoglobin relative to total hemoglobin in the blood
Time frame: 2 days
Rate of heart beat
Time frame: 2 days
Analyzed with video recording overnight
Time frame: 2 days
blood test with fasting status
Time frame: 2 days
blood test with fasting status
Time frame: 2 days
blood test with fasting status
Time frame: 2 days
blood test with fasting status
Time frame: 2 days
Indicator of oxidative stress
Time frame: 2 days
Indicator of oxidative stress
Kuang Tien General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04875364
Apnea, Dyssomnias
La Jolla, California, United States
View Trial DetailsNCT04007042
Alcohol Dependence, Alcohol-Related Disorders
Nîmes, Gard, France
View Trial DetailsNCT06283017
Apnea, Dyssomnias
Adelaide, South Australia, Australia
View Trial DetailsNCT06627127
Apnea, Dyssomnias
Wollongong, New South Wales, Australia
View Trial Details